NTLA offering history
Every offering-related filing in Intellia Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 711 filings back to Sep 3, 2015.
| Date | Filing | What it means | |
|---|---|---|---|
| Apr 29, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 27, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 2, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 26, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 23, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 24, 2023 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Dec 1, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 4, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 3, 2022 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jul 1, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 28, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 2, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 30, 2020 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Nov 30, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 3, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 1, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 1, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 12, 2019 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 30, 2019 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Aug 23, 2019 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 6, 2019 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 12, 2018 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Nov 3, 2017 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 1, 2017 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 16, 2017 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 5, 2017 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 17, 2016 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 6, 2016 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| May 5, 2016 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| May 5, 2016 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| May 5, 2016 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| May 5, 2016 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 27, 2016 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 19, 2016 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 12, 2016 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 11, 2016 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
NTLA offering FAQ
When did NTLA last execute an offering?
Per SEC filings, Intellia Therapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2026-04-29. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did NTLA last announce or register an offering?
The most recent registration is a S-3ASR filed 2023-11-24. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.